Dimensional Fund Advisors LP Verve Therapeutics, Inc. Transaction History
Dimensional Fund Advisors LP
- $391 Billion
- Q1 2025
A detailed history of Dimensional Fund Advisors LP transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 444,509 shares of VERV stock, worth $4.95 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
444,509
Previous 437,089
1.7%
Holding current value
$4.95 Million
Previous $2.47 Million
17.61%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VERV
# of Institutions
198Shares Held
79.9MCall Options Held
204KPut Options Held
101K-
Alphabet Inc. Mountain View, CA12.3MShares$137 Million5.03% of portfolio
-
Bvf Inc San Francisco, CA6.9MShares$76.8 Million1.39% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$73.7 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY4MShares$44.5 Million2.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.96MShares$44 Million0.0% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $667M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...